Dihexa

FDA APPROVAL PENDING

Dihexa

HGF/c-Met Agonist | Cognitive Enhancement & Neuroregeneration

Learn more

Cognitive

Dihexa

Longevity

Amino acid sequence

2

Amino acids

504.67da

Molecular weight

Peptide

Type

Dihexa (PNB-0408) is a synthetic oligopeptide derived from angiotensin IV, developed at Washington State University. It binds hepatocyte growth factor (HGF) and potentiates its signaling at the c-Met receptor, driving synaptogenesis at a potency reported to be seven orders of magnitude greater than BDNF in vitro. It is used in preclinical research focused on neurodegenerative disease, traumatic brain injury, and cognitive optimization.

Top researched benefits

Overview of Dihexa

Dihexa binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at the c-Met receptor on neuronal membranes, activating downstream PI3K/Akt and MAPK/ERK signaling cascades that upregulate synaptic proteins, promote dendritic growth, and drive new synapse formation in hippocampal neurons.

cognitive

  • Improvements in spatial, working, and consolidation demonstrated across animal models.
  • Enhanced acquisition through increased synaptic plasticity.
  • Restoration in impairment models including scopolamine-induced amnesia.

neuroprotection

  • Reduced amyloid burden in Alzheimer's models.
  • Decreased neuroinflammation and glial activation.
  • Protection of synapses in neurodegeneration models.

neuroplasticity

  • 3-fold increase in dendritic spine formation demonstrated.
  • Increases brain-derived neurotrophic factor expression.
  • Promotes new blood vessel formation in brain.

Typical Dose

10–15mg per dose

Frequency

once daily

Cycle Duration

4–6 weeks on, with extended off period due to long accumulation half-life

Storage

Lyophilized: store below -18°C; stable at room temperature up to 3 weeks. Reconstituted in bacteriostatic water: store at 2–8°C and use within 2–7 days, or freeze below -18°C for longer term; avoid repeated freeze-thaw cycles.

Chemical Makeup

Key benefits

Drives synaptogenesis in hippocampal neurons at potency reported to be 10 million times greater than BDNF in neurotrophic assays

Restored spatial learning and memory in APP/PS1 Alzheimer's mouse model, outperforming donepezil (Aricept) in Morris water maze tests

Reversed motor deficits in Parkinson's disease animal models following oral or subcutaneous administration

Increases dendritic spine density by 40–60% and upregulates synaptophysin (SYP) protein expression in preclinical neurodegeneration models

Community interest

This peptide is still gaining traction in the community.

HGF/c-Met Agonist | Cognitive Enhancement & Neuroregeneration

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

Dihexa Molecular Information

View the scientifc details of Dihexa.

2

Amino Acids

Dihexa

Tyr

Tyr

Position 1

Ile

Ile

Position 2

Amino acid sequence
TyrosinePosition 1
IsoleucinePosition 2

Molecular Weight

504.67Da

Chain Length

2Amino Acids

Type

Peptide

Dihexa Protocols

Subcutaneous injection delivers Dihexa directly into systemic circulation, bypassing first-pass hepatic metabolism and the variability of gastrointestinal absorption — though Dihexa is unusual among peptides in being orally bioavailable itself. Because Dihexa carries an approximately 12-day half-life, injected doses accumulate significantly over a multi-week protocol, so conservative starting doses are critical to avoid overshooting therapeutic targets.

GoalDosageFrequencyRoute
Promote initial synaptogenesis and improve learning capacity with a conservative dose that accounts for Dihexa's long half-life and cumulative build-up21 day rangeSubQ
Support ongoing synaptic density maintenance and neuroprotection against age-related cognitive decline at a mid-range therapeutic dose41 day rangeSubQ
Maximize synaptogenic and memory-consolidation effects in experienced users after tolerance has been established at lower doses71 day rangeSubQ
Target recovery of memory deficits and structural neural repair in the context of age-related neurodegeneration or traumatic brain injury sequelae51 day rangeSubQ
Reduce receptor desensitization risk and allow neural integration of synaptogenic changes by cycling Dihexa with mandatory off periods31 day rangeSubQ

Reconstitution Instructions

Materials needed:

Dihexa lyophilized powder vial (5 mg, 10 mg, or 15 mg)Bacteriostatic water (1–2 mL per vial)Insulin syringes (0.5–1 mL, 29–31 gauge)Alcohol swabsSharps disposal container

Steps to reconstitute

  1. Remove the lyophilized Dihexa vial from the freezer and allow it to reach room temperature for 10–15 minutes before reconstituting.
  2. Draw the required volume of bacteriostatic water into an insulin syringe — for a 10 mg vial, use 1 mL of BAC water to achieve a 10 mg/mL concentration; for a 15 mg vial, use 1.5 mL to achieve the same concentration.
  3. Insert the needle through the rubber stopper of the Dihexa vial at a slight angle and inject the BAC water slowly down the inside wall of the vial — never directly onto the lyophilized powder cake.
  4. Remove the syringe and gently swirl the vial in slow circular motions until the powder is fully dissolved. Do not shake or vortex, as mechanical shearing destroys peptide integrity and c-Met binding affinity.
  5. Inspect the solution — it should be clear and free of particulate matter. Discard if cloudy or discolored.
  6. Store the reconstituted vial refrigerated at 2–8°C, protected from light, and use within 14–28 days. Freeze unused aliquots at -20°C to extend stability, minimizing freeze-thaw cycles.
  7. At time of injection, draw the desired dose into a clean insulin syringe. Remove air bubbles by tapping the syringe and gently pressing the plunger until a drop appears at the needle tip.
  8. Clean the injection site (abdomen, thigh, or upper arm) with an alcohol swab and allow to air dry completely before injecting.
  9. Pinch a fold of skin, insert the needle at a 45-degree angle subcutaneously, aspirate briefly, then inject slowly and steadily.
  10. Remove the needle, apply gentle pressure with a clean swab, and log the injection site. Rotate sites each administration to prevent lipodystrophy.

Dihexa Cycle

The Dihexa Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 1-2
Subtle cognitive shifts; possible headaches during adaptation
Week 2-4
Improved focus and memory formation
Week 4-8
Peak cognitive benefits and enhanced learning
Week 0-0
Effects may persist for days to weeks after discontinuation

Dosing tools

Dihexa Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

mg

Enter the total amount of peptide in the vial in milligrams (as stated on the label).

The dose you want to inject per administration, in mcg or mg.

1,000 mcg = 1 mg

1 mL

2 mL

3 mL

5 mL

Custom

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

Injection Results

Based on your vial and dilution inputs.

Dihexa

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg Dihexa vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

1mL / 100 units

5 units

0.050 mL

Reference Guide

Dosing Cycle

Peptide
Dihexa
Dosing
10–15mg per dose
Dosing Frequency
once daily
Cycle Duration
4–6 weeks on, with extended off period due to long accumulation half-life
Storage
Lyophilized: store below -18°C; stable at room temperature up to 3 weeks. Reconstituted in bacteriostatic water: store at 2–8°C and use within 2–7 days, or freeze below -18°C for longer term; avoid repeated freeze-thaw cycles.

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of Dihexa interactions with other common peptides and substances.

Healing

bpc

Longevity

BPC-157

COMPATIBLE

Different mechanisms; no negative interactions known.

COMPATIBLE

Cognitive

cer

Longevity

Cerebrolysin

MONITOR

Both potently neuroactive; may cause overstimulation.

MONITOR

Longevity

nad

Metabolic

NAD+

COMPATIBLE

Complementary mechanisms for cellular health.

COMPATIBLE

Cognitive

p21

Longevity

P21

AVOID

Both affect neuroplasticity strongly; avoid concurrent use.

AVOID

Cognitive

sel

Longevity

Selank

COMPATIBLE

Synergistic effects; watch for neural overstimulation.

COMPATIBLE

Cognitive

sema

Longevity

Semax

COMPATIBLE

Enhanced cognitive benefits; monitor for overstimulation.

COMPATIBLE

Healing

tb5

Longevity

TB-500

COMPATIBLE

Different targets; no known interactions.

COMPATIBLE

Side effects

Avoid: Do not take Dihexa with P21.

Monitor: Be careful when combining Dihexa with Cerebrolysin.

Contraindications

Not FDA approved - research compound only

Theoretical cancer risk via c-Met activation

Cancer history (avoid due to c-Met pathway)

Pregnancy or breastfeeding

No long-term human safety data

Stop signs

Severe or persistent headaches

Increasing anxiety or panic attacks

Significant mood changes or depression

Sleep disturbance beyond 3 days

Concerning neurological symptoms

Signs of overstimulation or mania

Injection site reactions (if injectable)

Bad signs

No analytical testing or purity reportsUnverified sourcesSuspicious or extremely cheap pricingDiscolored or damaged capsules
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

DihexaResearch References

Dihexa is a preclinical compound

3Research references

Dihexa

Dihexa is a preclinical compound

Injectable Route Efficacy Study

Intraperitoneal injection at 0.5mg/kg/day completely reversed scopolamine-induced cognitive deficits (p<0.001), with performance indistinguishable from healthy controls.

2013

APP/PS1 Alzheimer's Model Study

Dihexa restored spatial learning and memory in Morris water maze tests, increased neuronal cells and synaptophysin expression, reduced neuroinflammation.

2021

Synaptogenic Potency Study

Demonstrated to be 10 million times more effective than BDNF at promoting synapse formation through HGF/c-Met receptor activation.

2014

Calculate peptide dosages

Learning how to calculate a peptide dose? Use our beginner-friendly peptide dosage, blend, and accumulation calculators. Enter vial size, reconstitution volume, and target dose to get exact draw volumes instantly. No guesswork, just clear guidance that helps prevent common mistakes.